Omega promo web banner
Omega promo Mobile banner

Glenmark Pharmaceuticals’ arm to launch generic Adderall tablets

17 Apr 2025 Evaluate

Glenmark Pharmaceuticals’ US-based subsidiary -- Glenmark Pharmaceuticals Inc, USA is all set to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a single entity Amphetamine product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg. These tablets are bioequivalent and therapeutically equivalent to the reference listed drug, Adderall 2 Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, of Teva Women’s Health, Inc. and the company will begin distribution in May 2025.

According to IQVIATM sales data for the 12-month period ending February 2025, the Adderall Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market3 achieved annual sales of approximately $421.7 million.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1653.75 -28.90 (-1.72%)
17-Jun-2025 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1648.85
Dr. Reddys Lab 1318.95
Cipla 1504.00
Lupin 1943.45
Zydus Lifesciences 954.00
View more..
Register Now to get our Free Newsletter & much more!
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...